Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
复制标题
DOI:
10.1056/nejmoa1814052
复制
发表时间:
2019-05-02
影响因子:
158.5
通讯作者:
Smith, C. R.
中科院分区:
文献类型:
--
作者:
Mack, M. J.;Leon, M. B.;Smith, C. R.
BACKGROUNDAmong patients with aortic stenosis who are at intermediate or high risk for death with surgery, major outcomes are similar with transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement. There is insufficient evidence regarding the comparison of the two procedures in patients who are at low risk.METHODSWe randomly assigned patients with severe aortic stenosis and low surgical risk to undergo either TAVR with transfemoral placement of a balloon-expandable valve or surgery. The primary end point was a composite of death, stroke, or rehospitalization at 1 year. Both noninferiority testing (with a prespecified margin of 6 percentage points) and superiority testing were performed in the as-treated population.RESULTSAt 71 centers, 1000 patients underwent randomization. The mean age of the patients was 73 years, and the mean Society of Thoracic Surgeons risk score was 1.9% (with scores ranging from 0 to 100% and higher scores indicating a greater risk of death within 30 days after the procedure). The Kaplan-Meier estimate of the rate of the primary composite end point at 1 year was significantly lower in the TAVR group than in the surgery group (8.5% vs. 15.1%; absolute difference, -6.6 percentage points; 95% confidence interval [CI], -10.8 to -2.5; P